| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | ivacaftor | FAERS: 2 | US FAERS | |
| 2 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 3 | Exenatide | FAERS: 1 | US FAERS | |
| 4 | Leuprolide | FAERS: 1 | US FAERS | |
| 5 | Ranolazine | FAERS: 1 | US FAERS | |
| 6 | ambrisentan | FAERS: 1 | US FAERS | |
| 7 | montelukast | FAERS: 1 | US FAERS | |
| 8 | regorafenib | FAERS: 1 | US FAERS | |
| 9 | rofecoxib | FAERS: 1 | US FAERS | |
| 10 | tofacitinib | FAERS: 1 | US FAERS | |
| 11 | treprostinil | FAERS: 1 | OFFSIDES US FAERS | |
| 12 | Aprepitant | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Famotidine | OFFSIDES | ||
| 14 | Triiodothyronine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.